These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 8732436)

  • 1. Comparative evaluation of in vitro and in vivo immunosuppressive potential of cyclosporin G with cyclosporin A and FK-506.
    Saada V; Pham-Huy C; Voisin J; Righenzi S; Rucay P; Claude JR; Duc HT
    Int J Immunopharmacol; 1996 Jan; 18(1):79-87. PubMed ID: 8732436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative investigation of the effects of the immunosuppressants cyclosporine A, cyclosporine G, and FK-506 on platelet activation.
    Fernandes JB; Naik UP; Markell MS; Kornecki E
    Cell Mol Biol Res; 1993; 39(3):265-74. PubMed ID: 7507391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinct mechanisms of suppression of murine T cell activation by the related macrolides FK-506 and rapamycin.
    Dumont FJ; Staruch MJ; Koprak SL; Melino MR; Sigal NH
    J Immunol; 1990 Jan; 144(1):251-8. PubMed ID: 1688572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of CD5 on B and T cells is suppressed by cyclosporin A, FK-520 and rapamycin.
    Teutsch M; Higer M; Wang D; Wortis HW
    Int Immunol; 1995 Mar; 7(3):381-92. PubMed ID: 7540861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic effects of Isatis tinctoria L. and tacrolimus in the prevention of acute heart rejection in mice.
    Wang Y; Qin Q; Chen J; Kuang X; Xia J; Xie B; Wang F; Liang H; Qi Z
    Transpl Immunol; 2009 Dec; 22(1-2):5-11. PubMed ID: 19766187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of the immunosuppressive effects of cyclosporine A and cyclosporine G in vivo and in vitro.
    Rayat G; Yatscoff R; Silverman R; McKenna R
    Transplantation; 1993 Mar; 55(3):623-6. PubMed ID: 8456482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unexpected up-regulation of gene expression by cyclosporin A and FK-506 in a T-cell lymphoma: both immunosuppressants augment Ly-6E antigen induction by interferon-gamma in the presence of ionomycin.
    Altmeyer A; Staruch MJ; Fischer PA; Durette PL; Tocci MJ; Sigal NH; Dumont FJ
    Int J Immunopharmacol; 1991; 13(8):1187-99. PubMed ID: 1726093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro and in vivo immunosuppressive potential of thalidomide and its derivative, N-hydroxythalidomide, alone and in combination with cyclosporin A.
    Chuong PH; Galons H; Voisin J; Zhu J; Righenzi S; Warnet JM; Claude JR; Huynh-Thien D
    Int J Immunopharmacol; 1997 May; 19(5):289-96. PubMed ID: 9439767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of cyclosporin A, FK 506, and mycalamide A on the activation of murine CD4+ T cells by the murine B7 antigen.
    Galvin F; Freeman GJ; Razi-Wolf Z; Benacerraf B; Nadler L; Reiser H
    Eur J Immunol; 1993 Jan; 23(1):283-6. PubMed ID: 7678228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The immunosuppressive macrolides FK-506 and rapamycin act as reciprocal antagonists in murine T cells.
    Dumont FJ; Melino MR; Staruch MJ; Koprak SL; Fischer PA; Sigal NH
    J Immunol; 1990 Feb; 144(4):1418-24. PubMed ID: 1689353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FK-506 and cyclosporin A inhibit highly similar signal transduction pathways in human T lymphocytes.
    Lin CS; Boltz RC; Siekierka JJ; Sigal NH
    Cell Immunol; 1991 Apr; 133(2):269-84. PubMed ID: 1707760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of the immunosuppressants cyclosporin A and FK 506 on exocytosis in the rat exocrine pancreas in vitro.
    Waschulewski IH; Hall DV; Kern HF; Edwardson JM
    Br J Pharmacol; 1993 Apr; 108(4):892-900. PubMed ID: 7683567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclosporin A, FK-506, and rapamycin: pharmacologic probes of lymphocyte signal transduction.
    Sigal NH; Dumont FJ
    Annu Rev Immunol; 1992; 10():519-60. PubMed ID: 1375473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human T cell responses to human and porcine endothelial cells are highly sensitive to cyclosporin A and FK506 in vitro.
    Batten P; McCormack AM; Page CS; Yacoub MH; Rose ML
    Transplantation; 1999 Nov; 68(10):1552-60. PubMed ID: 10589954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of T-lymphocyte activation by the immunosuppressive drug FK-506.
    Kay JE; Benzie CR; Goodier MR; Wick CJ; Doe SE
    Immunology; 1989 Aug; 67(4):473-7. PubMed ID: 2475433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effects of cyclosporins A and G on functional activation of a T-helper-lymphocyte line mediating experimental autoimmune uveoretinitis.
    Caspi RR; McAllister CG; Gery I; Nussenblatt RB
    Cell Immunol; 1988 May; 113(2):350-60. PubMed ID: 2965988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The immunosuppressive macrolides FK-506 and rapamycin.
    Thomson AW
    Immunol Lett; 1991 Jul; 29(1-2):105-11. PubMed ID: 1717376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclosporin A and FK-506 inhibit development of superantigen-potentiated collagen-induced arthritis in mice.
    Takaoka Y; Nagai H; Tanahashi M; Kawada K
    Gen Pharmacol; 1998 May; 30(5):777-82. PubMed ID: 9559334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunosuppressive effects of azelastine hydrochloride on contact hypersensitivity and T-cell proliferative response: a comparative study with FK-506.
    Furue M; Osada A; Chang CH; Tamaki K
    J Invest Dermatol; 1994 Jul; 103(1):49-53. PubMed ID: 7517981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of cyclosporin A, FK506, and rapamycin on the murine chronic graft-versus-host response--an in vivo model of Th2-like activity.
    Bundick RV; Craggs RI; Holness E
    Clin Exp Immunol; 1995 Mar; 99(3):467-72. PubMed ID: 7533681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.